By Emily Glazer
James Dimon, chairman and chief executive of J.P. Morgan Chase
& Co., on Tuesday told employees and shareholders he has been
diagnosed with throat cancer, that the prognosis is excellent and
that he will continue to be actively involved in the company during
his treatment.
Mr. Dimon, 58 years old, said he has briefed the bank's board on
his health. He said in a memo to employees and shareholders that he
will limit his travel during the roughly eight-week-long radiation
and chemotherapy treatment. Business will run as normal during his
treatment, he said, but he didn't elaborate beyond that. It wasn't
clear whether anyone would assume any of Mr. Dimon's
responsibilities during the treatment period.
The cancer was caught quickly and confined to one area, Mr.
Dimon said in the memo. He had tests including a CT scan and a
biopsy and learned the cancer is in his throat and the adjacent
lymph nodes on the right side of his neck.
"Importantly, there is no evidence of cancer elsewhere in my
body," he said in the memo. Mr. Dimon's evaluation and treatment
plan are still in the works, according to the memo.
"I feel very good now and will let all of you know if my health
situation changes," he said in the memo. Shares of J.P. Morgan were
little changed in after-hours trading.
Frank Bisignano, a longtime ally of Mr. Dimon's, also was
diagnosed with throat cancer several years ago when he was a top
executive at J.P. Morgan. Mr. Bisignano left J.P. Morgan last year
and is now chief executive of First Data Corp.
Robin Sidel contributed to this article.
Write to Emily Glazer at emily.glazer@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires